> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Heritage Pharma Charged in Price Fixing Scheme
- URL: https://www.fdaweb.com/heritage-pharma-charged-in-price-fixing-scheme/
- Published: 2019-06-03T12:00:00.000Z
- Updated: 2026-09-15T01:30:17.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144244

Generic drug maker Heritage Pharmaceuticals has been charged for conspiring with its competitors to fix prices, rig bids, and allocate customers, according to the [Justice Department](https://www.justice.gov/opa/pr/pharmaceutical-company-admits-price-fixing-violation-antitrust-law-resolves-related-false?ref=fdaweb.com). According to the government, from about 4/2014 to 12/2015, “Heritage participated in a criminal antitrust conspiracy with other companies and individuals engaged in the production and sale of generic pharmaceuticals, a purpose of which was to fix prices, rig bids, and allocate customers for glyburide, a medicine used to treat diabetes.”

Justice says that a deferred prosecution agreement resolving the charge has been drafted. Under the agreement’s terms, Heritage will pay a $225,000 criminal penalty and cooperate fully with the ongoing criminal investigation. The United States will defer prosecuting Heritage for a period of three years to allow the company to comply with the agreement’s terms. The agreement will not be final until accepted by the court.

In a separate civil resolution, Heritage has agreed to pay $7.1 million to resolve allegations under the False Claims Act related to the price-fixing conspiracy. The government alleged that between 2012 and 2015, Heritage paid and received remuneration through arrangements on price, supply, and allocation of customers with other pharmaceutical manufacturers for certain generic drugs in violation of the Anti-Kickback Statute, and that its sale of such drugs resulted in claims submitted to or purchases by federal healthcare programs. The drugs allegedly implicated in this scheme address a wide variety of health conditions, and include hydralazine, used to treat high blood pressure, theophylline, used to treat asthma and other respiratory problems, and glyburide.